benefits of sc natalizumab in ms
Published 3 years ago • 853 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
2:19
enhancing convenience and flexibility with sc natalizumab for ms
-
2:18
next-ms: personalized extended interval dosing of natalizumab in rrms
-
2:21
updates on natalizumab and anti-cd20 antibodies for ms
-
2:08
discovering markers of disease progression in patients with ms treated with natalizumab
-
3:30
long-term efficacy outcomes of natalizumab vs. fingolimod in highly active rrms
-
3:33
impact of natalizumab on chronic active ms lesions
-
1:16
natalizumab concentrations during pregnancy in ms patients
-
4:33
implications of extended dosing of natalizumab on wearing-off symptoms in ms patients
-
2:14
safely switching from natalizumab to ocrelizumab in patients with ms at risk of pml
-
3:10
natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active ms
-
10:21
additional insights from natalizumab treatment in ms
-
3:26
next-ms trial: natalizumab personalized extended interval dosing
-
9:21
what you need to know about natalizumab (tysabri®)
-
3:59
how is tysabri used in ms?
-
3:59
the comparative effectiveness of natalizumab and ocrelizumab in naïve relapsing remitting ms
-
3:53
natalizumab improves mental and social health in a real-world ms cohort
-
6:27
evaluating natalizumab’s risk-benefit profile in ms
-
7:07
review of natalizumab for ms
-
7:33
comparing exit strategies in natalizumab-responders at high risk for pml